SNTI Senti Biosciences, Inc. - Common Stock
$0.44
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$0–$3
5% of range
Analyst Rating
BUY
9 analysts
Price Target
$14
+2966% upside
P/E (TTM)
-0.4
ROE
—
Net Profit Margin
—
SNTI Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.44
Market Cap
—
P/E (TTM)
-0.4
EPS (TTM)
$-2.73
Revenue (TTM)
$22.0K
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $3
SNTI Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$22.0K
2021-12-31
→
2025-12-31
EPS
$-2.73
2021-12-31
→
2025-12-31
Free Cash Flow
—
2022-12-31
→
2024-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SNTI
Peer Median
P/E (TTM)
-0.4
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SNTI
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SNTI
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SNTI
Peer Median
Revenue YoY
-40.2%
—
Revenue CAGR 3Y
-82.8%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SNTI
Peer Median
SNTI Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
9 analysts
- Strong Buy 3 33.3%
- Buy 5 55.6%
- Hold 1 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-18
Median
$13.50
← Below all targets
$0.44
Low
$12.00
High
$15.00
Median target
$13.50
+2966.1%
Mean target
$13.50
+2966.1%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.6%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.36 | $-0.37 | 0.01% |
| Dec. 31, 2025 | $-0.53 | $-0.42 | -0.11% |
| Sept. 30, 2025 | $-0.69 | $-0.58 | -0.11% |
| June 30, 2025 | $-0.56 | $-0.92 | 0.36% |
| Dec. 31, 2024 | $-0.67 | $-3.19 | 2.5% |
| Sept. 30, 2023 | $2.40 | $-4.52 | 6.9% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SNTI | — | -0.4 | -40.2% | — | — | — |
| PASG | $38M | -0.8 | — | — | -159.7% | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| AIXC | — | -0.3 | — | — | — | — |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| PDSB | — | -1.0 | — | — | — | — |
| INTS | $1M | -0.0 | — | — | -165.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $22.0K | $0 | $3M | $4M | $3M | |
| R&D Expense | $38M | $34M | $32M | $28M | $22M | |
| SG&A Expense | $26M | $26M | $37M | $38M | $21M | |
| Operating Expenses | $69M | $61M | $95M | $66M | $43M | |
| Operating Income | $-69M | $-61M | $-93M | $-62M | $-40M | |
| Other Non-op | $800.0K | $200.0K | $-33.0K | $-32.0K | $-120.0K | |
| Income Tax | $0 | $0 | · | · | $0 | |
| Net Income | $-61M | $-53M | $-71M | $-58M | $-55M | |
| EPS (Basic) | $-2.73 | $-12.03 | $-16.01 | $-2.23 | $-19.00 | |
| EPS (Diluted) | $-2.73 | $-12.03 | $-16.01 | $-2.23 | $-19.00 | |
| Shares (Basic) | 22,483,391 | 4,595,946 | 4,437,106 | 26,110,785 | 2,912,275 | |
| Shares (Diluted) | 22,483,391 | 4,595,946 | 4,437,106 | 26,110,785 | 2,912,275 | |
| EBITDA | · | $-61M | · | $-71M | $-4M |
Balance Sheet 24
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $48M | $36M | $58M | $56M | |
| Short-term Investments | · | · | $0 | $41M | $0 | |
| Receivables | · | · | · | $626.0K | $483.0K | |
| Prepaid Expense | $1M | $1M | $3M | $2M | $4M | |
| Other Current Assets | $0 | $584.0K | $195.0K | $101.0K | $275.0K | |
| Current Assets | $23M | $59M | $71M | $103M | $60M | |
| PP&E (Net) | $13M | $21M | $25M | $51M | $12M | |
| PP&E (Gross) | $26M | $31M | $32M | $54M | $14M | |
| Accum. Depreciation | $13M | $10M | $6M | $3M | $2M | |
| Other Non-current Assets | $19.0K | $105.0K | $215.0K | $283.0K | $176.0K | |
| Total Assets | $51M | $98M | $119M | $181M | $97M | |
| Accounts Payable | $3M | $1M | $1M | $1M | $5M | |
| Accrued Liabilities | · | · | · | · | $3M | |
| Current Liabilities | $14M | $13M | $13M | $18M | $15M | |
| Capital Leases | $24M | $29M | $34M | $35M | $21M | |
| Other Non-current Liabilities | $8M | $5M | $0 | · | · | |
| Total Liabilities | $46M | $47M | $53M | $54M | $36M | |
| Common Stock | $3.0K | $1.0K | $1.0K | $4.0K | $0 | |
| Paid-in Capital | $364M | $323M | $311M | $301M | $4M | |
| Retained Earnings | $-359M | $-297M | $-244M | $-173M | $-115M | |
| AOCI | · | · | $0 | $1.0K | $0 | |
| Stockholders' Equity | $6M | $26M | $67M | $127M | $-111M | |
| Liabilities + Equity | $51M | $98M | $119M | $181M | $97M | |
| Shares Outstanding | 30,879,355 | 4,829,035 | 4,569,900 | 4,406,137 | 2,972,409 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $2M | $10M | $16M | $2M | |
| Operating Cash Flow | $-43M | $-41M | $-52M | $-35M | $-35M | |
| CapEx | $196.0K | $26.0K | $12M | $41M | $6M | |
| Investing Cash Flow | $-184.0K | $34.0K | $30M | $-82M | $-6M | |
| Stock Issued | · | $2M | $512.0K | $728.0K | $0 | |
| Net Stock Activity | · | $2M | · | $728.0K | · | |
| Financing Cash Flow | $12M | $54M | $779.0K | $119M | $68M | |
| Net Change in Cash | $-32M | $12M | $-22M | $2M | $28M | |
| Taxes Paid | $0 | $0 | · | · | · | |
| Free Cash Flow | · | $-41M | · | $-76M | · |
Profitability 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1647.9% | · | |
| Net Margin | · | · | · | -1358.1% | · | |
| EBITDA Margin | · | · | · | -1647.9% | · | |
| ROA | · | -48.6% | · | -41.9% | -3.3% | |
| ROE | · | -253.5% | · | -43.5% | 7.0% |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | · | 4.5 | · | 5.7 | 0.4 | |
| Quick Ratio | · | 3.7 | · | 5.5 | 0.3 |
Efficiency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | · | |
| Receivables Turnover | · | · | · | 7.7 | · |
Growth Rates 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -40.2% | 55.2% | · | |
| Revenue CAGR 3Y | -82.8% | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $22.0K | $0 | $3M | $4M | $3M | |
| Net Income TTM | $-61M | $-53M | $-71M | $-58M | $-55M | |
| Market Cap | · | $17M | · | $621M | · | |
| P/E | -0.4 | -0.3 | -0.4 | -6.3 | -5.2 | |
| P/S | · | · | · | 145.0 | · | |
| P/B | · | 0.7 | · | 4.9 | · | |
| P / Tangible Book | 5.7 | 0.7 | 4.5 | 4.9 | · | |
| P / Cash Flow | · | -0.4 | · | -17.8 | · | |
| P / FCF | · | -0.4 | · | -8.1 | · | |
| Earnings Yield | -262.5% | -342.7% | -242.6% | -15.8% | -19.3% |
Income Statement 13
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.0K | $16.0K | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $338.0K | $937.0K | $1M | $58.0K | $2M | |
| R&D Expense | $8M | $5M | $8M | $11M | $10M | $9M | $8M | $9M | $9M | $9M | $9M | $9M | $7M | $7M | $5M | $7M | |
| SG&A Expense | $7M | $6M | $6M | $6M | $7M | $7M | $8M | $7M | $4M | $8M | $9M | $9M | $9M | $9M | $9M | $10M | |
| Operating Expenses | $15M | $5M | $19M | $17M | $17M | $16M | $16M | $15M | $13M | $16M | $19M | $44M | $16M | $16M | $14M | $17M | |
| Operating Income | $-14M | $-5M | $-19M | $-17M | $-17M | $-16M | $-16M | $-15M | $-13M | $-16M | $-19M | $-44M | $-15M | $-15M | $-14M | $-15M | |
| Other Non-op | $2M | $200.0K | $190.0K | $223.0K | $2M | $178.0K | $205.0K | $-11.0K | $6.0K | $0 | $-7.0K | $-14.0K | $-4.0K | $-8.0K | $-5.0K | $2.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $-13M | $-4M | $-14M | $-18M | $-15M | $-14M | $-610.0K | $-29M | $-11M | $-12M | $-19M | $-15M | $-19M | $-19M | $-58M | $-17M | |
| EPS (Basic) | $-0.41 | $-0.14 | $-0.07 | $-0.69 | $-0.56 | $-1.41 | $-0.62 | $-6.31 | $-2.45 | $-2.65 | $-8.01 | $-3.36 | $-4.22 | $-0.42 | $2.73 | $-0.38 | |
| EPS (Diluted) | $-0.41 | $-0.14 | $-0.07 | $-0.69 | $-0.56 | $-1.41 | $-0.62 | $-6.31 | $-2.45 | $-2.65 | $-8.01 | $-3.36 | $-4.22 | $-0.42 | $2.73 | $-0.38 | |
| Shares (Basic) | 31,144,754 | 30,971,573 | -39,839,064 | 26,228,274 | 26,081,273 | 10,012,908 | -9,123,930 | 4,577,122 | 4,572,010 | 4,570,744 | -48,508,817 | 4,447,223 | 4,427,726 | 44,070,974 | -33,931,263 | 43,424,172 | |
| Shares (Diluted) | 31,144,754 | 30,971,573 | -39,839,064 | 26,228,274 | 26,081,273 | 10,012,908 | -9,123,930 | 4,577,122 | 4,572,010 | 4,570,744 | -48,508,817 | 4,447,223 | 4,427,726 | 44,070,974 | -33,931,263 | 43,424,172 | |
| EBITDA | $-14M | $-5M | · | $-17M | $-17M | $-16M | · | $-15M | $-13M | $-16M | · | $-44M | $-20M | $-20M | · | $-17M |
Balance Sheet 23
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $9M | $16M | $12M | $22M | $34M | $48M | $10M | $16M | $24M | $36M | $39M | $37M | $32M | $58M | $115M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $23M | $45M | $41M | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | $567.0K | $791.0K | · | $846.0K | |
| Prepaid Expense | $623.0K | $2M | $1M | $2M | $2M | $3M | $1M | $1M | $2M | $3M | $3M | $3M | $3M | $4M | $2M | $4M | |
| Other Current Assets | $288.0K | · | $0 | $0 | $0 | $0 | $584.0K | $8.0K | $20.0K | $0 | $195.0K | $488.0K | $139.0K | $112.0K | $101.0K | $56.0K | |
| Current Assets | $13M | $15M | $23M | $18M | $33M | $45M | $59M | $17M | $44M | $56M | $71M | $79M | $63M | $81M | $103M | $120M | |
| PP&E (Net) | $11M | $12M | $13M | $19M | $20M | $21M | $21M | $22M | $23M | $24M | $25M | $26M | $59M | $59M | $51M | $47M | |
| PP&E (Gross) | $26M | $26M | $26M | $31M | $31M | $31M | $31M | $31M | $31M | $31M | $32M | $32M | $63M | $62M | $54M | $50M | |
| Accum. Depreciation | $14M | $14M | $13M | $12M | $11M | $10M | $10M | $9M | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $0 | $5.0K | $19.0K | $34.0K | $52.0K | $76.0K | $105.0K | $88.0K | $76.0K | $86.0K | $215.0K | $177.0K | $393.0K | $471.0K | $283.0K | $243.0K | |
| Total Assets | $33M | $38M | $51M | $53M | $69M | $83M | $98M | $58M | $87M | $102M | $119M | $132M | $144M | $161M | $181M | $189M | |
| Accounts Payable | $2M | $1M | $3M | $2M | $1M | $2M | $1M | $793.0K | $1M | $2M | $1M | $2M | $3M | $3M | $1M | $2M | |
| Current Liabilities | $16M | $14M | $14M | $12M | $10M | $11M | $13M | $9M | $9M | $10M | $13M | $10M | $10M | $13M | $18M | $16M | |
| Capital Leases | $13M | $13M | $24M | $25M | $26M | $28M | $29M | $30M | $31M | $32M | $34M | $35M | $36M | $36M | $35M | $32M | |
| Other Non-current Liabilities | $8M | $8M | $8M | $8M | $8M | $7M | $5M | $3M | · | · | $0 | · | · | · | · | · | |
| Total Liabilities | $37M | $36M | $46M | $45M | $44M | $45M | $47M | $42M | $43M | $46M | $53M | $49M | $46M | $49M | $54M | $49M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $1.0K | $1.0K | $1.0K | $5.0K | $1.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $372M | $365M | $364M | $352M | $351M | $349M | $323M | $313M | $312M | $313M | $311M | $309M | $308M | $304M | $301M | $295M | |
| Retained Earnings | $-376M | $-363M | $-359M | $-344M | $-326M | $-311M | $-297M | $-297M | $-268M | $-256M | $-244M | $-226M | $-211M | $-192M | $-173M | $-155M | |
| AOCI | · | · | · | · | · | · | · | · | · | $0 | · | $0 | $0 | $3.0K | $1.0K | · | |
| Stockholders' Equity | $-3M | $3M | $6M | $8M | $25M | $38M | $26M | $16M | $44M | $56M | $67M | $83M | $97M | $112M | $127M | $140M | |
| Liabilities + Equity | $33M | $38M | $51M | $53M | $69M | $83M | $98M | $58M | $87M | $102M | $119M | $132M | $144M | $161M | $181M | $189M | |
| Shares Outstanding | 31,144,754 | 31,144,754 | 30,879,355 | 26,290,838 | 26,160,206 | 26,004,366 | 4,829,035 | 4,586,957 | 4,572,432 | 45,712,821 | 4,569,900 | 44,477,666 | 44,465,006 | 44,075,194 | 44,062,534 | 43,638,917 |
Cash Flow 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $2M | $2M | $1M | $605.0K | $668.0K | $-776.0K | $1M | $2M | $409.0K | $3M | $4M | $4M | $2M | |
| Operating Cash Flow | $-14M | $-7M | $-7M | $-9M | $-13M | $-14M | $-14M | $-8M | $-8M | $-12M | $-7M | $-15M | $-14M | $-16M | $-9M | $-10M | |
| CapEx | · | · | $0 | $0 | $196.0K | $0 | $11.0K | $0 | $0 | $15.0K | $4.0K | $2M | $4M | $7M | $9M | $14M | |
| Investing Cash Flow | $0 | $114.0K | $0 | $0 | $-184.0K | $0 | $-11.0K | $60.0K | $0 | $-15.0K | $101.0K | $21M | $18M | $-9M | $-49M | $-14M | |
| Stock Issued | · | · | · | · | · | · | · | $10.0K | · | · | $204.0K | $0 | · | · | · | · | |
| Financing Cash Flow | $10M | $-118.0K | $11M | $124.0K | $1M | $-414.0K | $51M | $2M | $0 | $0 | $556.0K | $-23.0K | $281.0K | $-35.0K | $876.0K | $-485.0K | |
| Net Change in Cash | $-5M | $-7M | $4M | $-9M | $-12M | $-14M | $38M | $-5M | $-8M | $-12M | $-6M | $6M | $5M | $-26M | $-57M | $-25M | |
| Free Cash Flow | · | · | · | · | · | $-14M | · | · | · | $-12M | · | · | · | $-23M | · | · |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -85229.4% | -28850.0% | · | · | · | · | · | · | · | · | · | -12981.1% | -2095.5% | -1542.3% | · | -967.4% | |
| Net Margin | -75000.0% | -26381.2% | · | · | · | · | · | · | · | · | · | -4415.1% | -1995.4% | -1455.8% | · | -942.2% | |
| EBITDA Margin | -85229.4% | -28850.0% | · | · | · | · | · | · | · | · | · | -12981.1% | -2095.5% | -1542.3% | · | -967.4% | |
| ROA | -25.1% | -7.0% | · | -32.8% | -18.9% | -15.3% | · | -30.5% | -9.7% | -9.2% | · | -9.3% | -10.8% | -9.5% | · | -7.9% | |
| ROE | -120.0% | -20.9% | · | -150.3% | -42.8% | -30.0% | · | -58.4% | -15.8% | -14.4% | · | -13.4% | -14.9% | -36.6% | · | -24.9% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.0 | · | 1.5 | 3.3 | 4.2 | · | 1.9 | 4.9 | 5.8 | · | 7.8 | 6.1 | 6.3 | · | 7.6 | |
| Quick Ratio | 0.4 | 0.6 | · | 1.0 | 2.2 | 3.2 | · | 1.2 | 1.7 | 2.5 | · | 3.9 | 5.8 | 6.0 | · | 7.3 |
Efficiency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 3.3 | 3.3 | · | 4.2 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $338.0K | $338.0K | $338.0K | · | $338.0K | $1M | $3M | · | $4M | $5M | $6M | · | $5M | |
| Net Income TTM | $-50M | $-51M | · | $-76M | $-69M | $-66M | · | $-123M | $-109M | $-117M | · | $-111M | $-112M | $-105M | · | $-51M | |
| Market Cap | $34M | $25M | · | $37M | $55M | $87M | · | $10M | $13M | $172M | · | $184M | $279M | $520M | · | $947M | |
| P/E | -0.6 | -0.3 | · | -0.2 | -0.2 | -0.3 | · | -0.2 | -0.2 | -0.4 | · | -0.5 | -1.1 | -2.2 | · | -2.4 | |
| P/S | · | · | · | 109.7 | 163.3 | 258.5 | · | 30.7 | 9.9 | 67.3 | · | 42.5 | 52.1 | 94.3 | · | 177.6 | |
| P/B | -10.1 | 9.9 | · | 4.6 | 2.2 | 2.3 | · | 0.6 | 0.3 | 3.1 | · | 2.2 | 2.9 | 4.6 | · | 6.7 | |
| P / Tangible Book | · | 9.9 | · | 4.6 | 2.2 | 2.3 | · | 0.6 | 0.3 | 3.1 | · | 2.2 | 2.9 | 4.6 | · | 6.7 | |
| P / Cash Flow | · | -3.4 | · | · | · | -6.2 | · | · | · | -14.8 | · | · | · | -31.9 | · | · | |
| P / FCF | · | · | · | · | · | -6.2 | · | · | · | -14.7 | · | · | · | -22.8 | · | · | |
| Earnings Yield | -163.6% | -344.8% | · | -636.2% | -508.5% | -381.6% | · | -653.5% | -459.4% | -282.5% | · | -202.9% | -93.8% | -45.6% | · | -40.8% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $22.0K | $0 | $3M | $4M | $3M |
| Operating Margin % | — | — | — | -1647.9% | — |
| Net Income | $-61M | $-53M | $-71M | $-58M | $-55M |
| Diluted EPS | $-2.73 | $-12.03 | $-16.01 | $-2.23 | $-19.00 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | — | 4.5 | — | 5.7 | 0.4 |
| Quick Ratio | — | 3.7 | — | 5.5 | 0.3 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-41M | — | $-76M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 3 filers · $4.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 | 13 | 0 | 0 | — |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| NEA Management Company, LLC | $4,153,177 | 3,775,615 | 87.45% | Shares |
| VANGUARD GROUP INC | $559,004 | 537,504 | 11.77% | Shares |
| MSOP GP, L.L.C. | $37,166 | 35,737 | 0.78% | Shares |
Company insiders 12 insiders · 1 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Kanya Rajangam | Chief Medical & Devt. Officer | July 18, 2022 A | — | 0 | 0 | $0 |
| Feng Hsiung | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| Fran Schulz | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| Brenda Cooperstone | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| Donald F Tang | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| James J. Collins | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| Edward T. Mathers | Director | June 25, 2025 A | — | 0 | 0 | $0 |
| Omid Farokhzad | Director | July 13, 2022 A | 250,000 | 0 | 0 | $0 |
| David R Epstein | Director | July 13, 2022 A | 123,252 | 0 | 0 | $0 |
| Susan D Berland | Director | July 13, 2022 A | — | 0 | 0 | $0 |
| Dynamics Sponsor LLC | Director | June 8, 2022 M | 0 | 0 | 0 | $0 |
| Celadon Partners SPV 24 | 10% owner | March 10, 2025 C | 9,777,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Celadon Partners SPV 24, Celadon Partners, LLC, CPIF II-7 Limited ×6 filings | July 16, 2026 | 54.60% | Amendment | M&A / sale | SEC |
| Bayer HealthCare LLC, Bayer US Holding LLC, Sebastian Guth, Priyal Patel ×2 filings | April 16, 2026 | 17.82% | Amendment | — | SEC |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 filings | March 31, 2026 | 12.10% | Amendment | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.